NDC 64193-423

FEIBA

Anti-inhibitor Coagulant Complex

FEIBA is a Kit in the Human Prescription Drug category. It is labeled and distributed by Baxalta Incorporated. The primary component is .

• Product ID: 64193-423_4043cc82-6f4d-4241-b6a0-e55a92c5e53b
• NDC: 64193-423
• Product Type: Human Prescription Drug
• Proprietary Name: FEIBA
• Generic Name: Anti-inhibitor Coagulant Complex
• Dosage Form: Kit
• Marketing Start Date: 1986-01-31
• Marketing Category: BLA / BLA
• Application Number: BLA101447
• Labeler Name: Baxalta Incorporated
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC SPL Data Element Entries

NDC 64193-423-02 [64193042302]

FEIBA KIT

• Marketing Category: BLA
• Application Number: BLA101447
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1986-01-31
• Marketing End Date: 2019-03-31

Drug Details

OpenFDA Data

• SPL SET ID: 752604e5-4ea2-44f4-83ed-1569373f6412
• Manufacturer:
  • Baxalta Incorporated
• RxNorm Concept Unique ID - RxCUI:
  • 1659998
  • 1660001

NDC Crossover Matching brand name "FEIBA" or generic name "Anti-inhibitor Coagulant Complex"

NDC	Brand Name	Generic Name
64193-423	FEIBA	anti-inhibitor coagulant complex
64193-424	FEIBA	anti-inhibitor coagulant complex
64193-425	FEIBA	anti-inhibitor coagulant complex
64193-426	FEIBA	anti-inhibitor coagulant complex